Showing results (61-70 of 165) with videos related to
Sort By:
Pageof 17
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 1, 1992
Effects of stimulation of putative dopamine autoreceptors on electroencephalographic power spectrum in comparison with effects produced by blockade of postsynaptic dopamine receptors in ratsW Kropf, J Krieglstein, K KuschinskyJournal of Pharmacological Methods|August 1, 1988
Cultured neurons for testing cerebroprotective drug effects in vitroJ Krieglstein, H Brungs, B PerucheNeurochemistry International|July 14, 1999
NGF mediates the neuroprotective effect of the beta2-adrenoceptor agonist clenbuterol in vitro and in vivo: evidence from an NGF-antisense studyC Culmsee, I Semkova, J KrieglsteinJournal of Neuroscience Research|June 22, 2000
Retinoic acid potentiated the protective effect of NGF against staurosporine-induced apoptosis in cultured chick neurons by increasing the trkA protein expressionB Ahlemeyer, R Hühne, J KrieglsteinNaunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1988
Uncoupling of cerebral blood flow and glucose utilization by dihydroergocristine in the conscious ratT Beck, P Vogg, J KrieglsteinStroke|December 1, 1990
Neuroprotective effect of nimodipine is not mediated by increased cerebral blood flow after transient forebrain ischemia in ratsM Welsch, J Nuglisch, J KrieglsteinEuropean Journal of Pharmacology|March 17, 1999
Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituentsB Ahlemeyer, A Möwes, J KrieglsteinNaunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1984
Comparison of rat brain and heart mitochondrial hexokinase solubilized by methohexitalL Karcher, A Rachman, J KrieglsteinPharmacology|January 1, 1991
Preischemic administration of flunarizine or phencyclidine reduces local cerebral glucose utilization in rat hippocampus seven days after ischemiaJ Nuglisch, R Rischke, J KrieglsteinEuropean Journal of Pharmacology|December 1, 1998
Neuroprotective effect of 5-HT1A receptor agonist, Bay X 3702, demonstrated in vitro and in vivoI Semkova, P Wolz, J KrieglsteinPageof 17